| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/27/2011 | CN101313943B Chinese medicinal composition for treating nephropathy and preparation thereof |
| 07/27/2011 | CN101306001B Use of 2'-O-beta-D-glucopyranose-momordin Ic or plant extract containing same in preparing alpha-glucosidase inhibitor or invertase inhibitor |
| 07/27/2011 | CN101282977B Xanthine derivatives as selective hm74a agonists |
| 07/27/2011 | CN101249176B Chinese medicine prescription for steaming and soaking foots |
| 07/27/2011 | CN101193885B Benzofuran derivative as 5-HT6 receptor inhibitor |
| 07/27/2011 | CN101095718B Method for preparation of coffee pellets for slimming |
| 07/27/2011 | CN101067146B Biological extraction process of glycyrrhizic acid |
| 07/27/2011 | CN101066316B Composite litchi-male silk moth nutrient liquid and its preparation method |
| 07/26/2011 | US7985760 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase |
| 07/26/2011 | US7985744 Vitamin D derivatives |
| 07/26/2011 | US7985563 HIFαprolyl hydroxylation assay |
| 07/26/2011 | US7985386 Implantable medical device for diagnostic sensing |
| 07/26/2011 | CA2729522A1 Supplement composition and method of use |
| 07/26/2011 | CA2621134C Pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof |
| 07/26/2011 | CA2571361C Pyrimidine derivatives as 11beta-hsd1 inhibitors |
| 07/26/2011 | CA2530452C Indolyl derivatives substituted with a thiazole ring and their use as ppar modulators |
| 07/26/2011 | CA2502877C Metastable benzoxepine derivatives which can be used in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them and processes forthe preparation thereof |
| 07/26/2011 | CA2484981C 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 07/26/2011 | CA2484482C Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 07/26/2011 | CA2463615C Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 07/26/2011 | CA2445344C Heterocyclic compound derivatives and medicines |
| 07/26/2011 | CA2367787C Ligands for metabotropic glutamate receptors |
| 07/21/2011 | WO2011088055A2 Methods and compositions for treating cardiovascular disorders |
| 07/21/2011 | WO2011087981A2 Clinical benefits of eicosapentaenoic acid in humans |
| 07/21/2011 | WO2011087964A1 Methods of treating glucose metabolism disorders |
| 07/21/2011 | WO2011087713A2 Tricyclic derivatives and their pharmaceutical use and compositions |
| 07/21/2011 | WO2011087672A1 Oxyntomodulin peptide analogue |
| 07/21/2011 | WO2011087671A1 Oxyntomodulin peptide analogue |
| 07/21/2011 | WO2011087102A1 Therapeutic agent for promoting recovery of animal under medical treatment |
| 07/21/2011 | WO2011087024A1 Insulin preparation |
| 07/21/2011 | WO2011087009A1 Regulatory gene controlling saccharometabolism, lipid metabolism, obesity and life, protein, and screening method |
| 07/21/2011 | WO2011086163A1 Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors |
| 07/21/2011 | WO2011086077A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | WO2011085979A1 Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions |
| 07/21/2011 | WO2011085643A1 Fused pyridine derivatives |
| 07/21/2011 | WO2011085602A1 Protein hydrolysate, polypeptide solution and polypeptide, preparation method and use thereof |
| 07/21/2011 | WO2011059170A3 Method for extracting aromatic substance from traditional chinese herb medicines |
| 07/21/2011 | WO2011050163A9 Method of preventing type 1 diabetes |
| 07/21/2011 | WO2011028941A3 Disabling autophagy as a treatment for lysosomal storage diseases |
| 07/21/2011 | WO2011025932A3 Preparation of sitagliptin and salts thereof |
| 07/21/2011 | WO2010071783A8 Thiazoles as cannabinoid receptor ligands |
| 07/21/2011 | US20110178183 Use Of Polyether-Based And Vinyl Monomer-Based Copolymers As Binders For Dosing Forms Comprising Solid Active Ingredients |
| 07/21/2011 | US20110178175 Method for producing mechanically activated amorphous and amorphocrystalline compounds of gluconic acid calcium salt |
| 07/21/2011 | US20110178151 Compounds and methods of treating obesity |
| 07/21/2011 | US20110178146 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 07/21/2011 | US20110178141 Thiazoliums and Their Use for Treating Protein Aging Associated Diseases |
| 07/21/2011 | US20110178140 Sulfur containing pyrazole-heterocycle derivatives as cannabinoid cb1 receptor antagonists |
| 07/21/2011 | US20110178139 Pyridoxamine for the Treatment of Diabetic Kidney Disease |
| 07/21/2011 | US20110178134 Novel phenyl-substituted imidazolidines, process for preparation thereof, medicaments comprising said compounds and use thereof |
| 07/21/2011 | US20110178133 Calcium receptor modulating agents |
| 07/21/2011 | US20110178130 MACROCYCLIC UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa |
| 07/21/2011 | US20110178112 PPAR Modulators |
| 07/21/2011 | US20110178105 Clinical benefits of eicosapentaenoic acid in humans |
| 07/21/2011 | US20110178099 Pharmaceutical combination |
| 07/21/2011 | US20110178096 Octahydropentalene compounds as chemokine receptor antagonists |
| 07/21/2011 | US20110178090 Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof |
| 07/21/2011 | US20110178089 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds |
| 07/21/2011 | US20110178083 Pde-10 inhibitors |
| 07/21/2011 | US20110178082 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/21/2011 | US20110178081 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/21/2011 | US20110178080 Melanocortin Receptor-Specific Spiro-Piperidine Compounds |
| 07/21/2011 | US20110178078 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof |
| 07/21/2011 | US20110178075 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 07/21/2011 | US20110178054 Heterocyclic GPCR Agonists |
| 07/21/2011 | US20110178045 Method to induce fatty liver in animal |
| 07/21/2011 | US20110178044 Transdermal administration of hydrophilic drugs using permeation enhancer composition |
| 07/21/2011 | US20110178041 Heterocyclic biaryl derivative and pde inhibitor comprising same as active ingredient |
| 07/21/2011 | US20110178033 Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 07/21/2011 | US20110178017 Modified vasoactive intestinal peptides |
| 07/21/2011 | US20110178013 Novel octapeptide compounds derived from somatostatin and the therapeutic use thereof |
| 07/21/2011 | US20110178012 Use of human chorionic gonadotropin orally for the treatment of overweight (obesity) associated with high blood tension, non-insulin-dependant diabetes, hypercholesterolemia, dyslipidemias and lipodystrophy. |
| 07/21/2011 | US20110178008 Compositions for Enhancing the Production of PPAR and/or PPAR-Associated Factors |
| 07/21/2011 | US20110178007 Spiro-imidazolone derivatives as glucagon receptor antagonists |
| 07/21/2011 | US20110178006 Method for administering glp-1 molecules |
| 07/21/2011 | US20110178005 Compositions and methods for treating disorders associated with overweight animals |
| 07/21/2011 | US20110177595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
| 07/21/2011 | US20110177177 Herbal extract as sensitivity enhancer toward insulin and antidiabetes |
| 07/21/2011 | US20110177174 Fruit chocolate |
| 07/21/2011 | US20110177166 Galenical Formulation Comprising Aliskiren and Process for its Preparation by Melt Extrusion Granulation |
| 07/21/2011 | US20110177150 Implantable tissue compositions and method |
| 07/21/2011 | US20110177126 Bacteria and derived products to reinforce the body defences and to reduce the risk of disease |
| 07/21/2011 | US20110177113 Use of antrodia camphorata for treating diseases |
| 07/21/2011 | US20110177106 Novel Therapeutic Methods for Treating Inflammation and Immune System Disorders |
| 07/21/2011 | US20110177098 Tm4sf4 and modulators thereof and methods for their use |
| 07/21/2011 | US20110177097 Methods for modulating expression of creb |
| 07/21/2011 | US20110177066 Prevention and treatment of amyloidogenic diseases |
| 07/21/2011 | US20110177054 Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna |
| 07/21/2011 | US20110177046 Dithiazolidine and thiazolidine derivatives as anticancer agents |
| 07/21/2011 | US20110177010 Vitamin preparation |
| 07/21/2011 | US20110176997 Method to make porous materials and their applications |
| 07/21/2011 | DE102009025119B4 Antitumorale, antibiotische und insektizide Cyclodepsipeptide, deren Herstellung und Verwendungen Antitumoral, antibiotic and insecticidal cyclodepsipeptides, their preparation and uses |
| 07/21/2011 | CA2799474A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | CA2786476A1 Methods of treating glucose metabolism disorders |
| 07/21/2011 | CA2785455A1 Tricyclic derivatives and their pharmaceutical use and compositions |
| 07/21/2011 | CA2785262A1 Nutritional compositions and methods for optimizing dietary acid-base potential |
| 07/21/2011 | CA2784671A1 Oxyntomodulin peptide analogue |
| 07/21/2011 | CA2784668A1 Oxyntomodulin peptide analogue |
| 07/20/2011 | EP2345720A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 07/20/2011 | EP2345672A1 Anti-glycated cd59 antibodies and uses thereof |
| 07/20/2011 | EP2345416A1 Pharmaceutical composition for purifing vein and preparation method thereof |